Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Lucas

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Lancet (London, England)|September 10, 1994
Thrombogenic potential of factor XI concentrateP H Bolton-Maggs, B T Colvin, B T Satchi, et al.
Leukemia|February 1, 1993
Polymerase chain reaction analysis of allele frequency and loss at the Harvey ras locus in myeloid malignanciesJ C Ardern, M J Saunders, K Hyde, et al.
Leukemia|June 8, 2007
The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cellsJ Burthem, K Rees-Unwin, R Mottram, et al.
Molecular Medicine (Cambridge, Mass.)|December 29, 2000
The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cellsA M Buckle, R Mottram, A Pierce, et al.
Journal of Clinical Pathology|December 25, 2002
Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosisM Jeziorska, A Hassan, M I Mackness, et al.
Biorheology. Supplement : the Official Journal of the International Society of Biorheology|January 1, 1984
Anticoagulants and erythrocyte filterabilityJ Stuart, G S Lucas, N M Caldwell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
HLA-DR15, reduced relapse rate and improved survival after HLA identical sibling hemopoietic stem cell transplantationJ A Davidson, D G Tate, K V Poulton, et al.
Blood|January 29, 2000
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapseK Tobal, J Newton, M Macheta, et al.
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Lancet (London, England)|September 10, 1994
Thrombogenic potential of factor XI concentrateP H Bolton-Maggs, B T Colvin, B T Satchi, et al.
Leukemia|February 1, 1993
Polymerase chain reaction analysis of allele frequency and loss at the Harvey ras locus in myeloid malignanciesJ C Ardern, M J Saunders, K Hyde, et al.
Leukemia|June 8, 2007
The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cellsJ Burthem, K Rees-Unwin, R Mottram, et al.
Molecular Medicine (Cambridge, Mass.)|December 29, 2000
The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cellsA M Buckle, R Mottram, A Pierce, et al.
Journal of Clinical Pathology|December 25, 2002
Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosisM Jeziorska, A Hassan, M I Mackness, et al.
Biorheology. Supplement : the Official Journal of the International Society of Biorheology|January 1, 1984
Anticoagulants and erythrocyte filterabilityJ Stuart, G S Lucas, N M Caldwell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
HLA-DR15, reduced relapse rate and improved survival after HLA identical sibling hemopoietic stem cell transplantationJ A Davidson, D G Tate, K V Poulton, et al.
Blood|January 29, 2000
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapseK Tobal, J Newton, M Macheta, et al.
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
Pageof 3